AVEO commences underwritten public offering of shares of common stock

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by AVEO.

J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers. AVEO intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the amount of shares sold in the offering to cover over-allotments, if any. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.